Literature DB >> 7929771

Restriction fragment length polymorphism analysis of clinical isolates of Mycobacterium haemophilum.

K Kikuchi1, E M Bernard, T E Kiehn, D Armstrong, L W Riley.   

Abstract

Mycobacterium haemophilum is an emerging opportunistic pathogen, and since 1989, infections caused by this organism have been identified more frequently in the New York City area than in any other region of the United States. A DNA fingerprinting method, based on restriction fragment length polymorphisms (RFLPs) was developed. A genomic library of M. haemophilum isolate 1A was constructed; screening the library yielded a recombinant strain that incorporated a genetic element present in multiple copies in the M. haemophilum genome. This clone was used to produce a probe for RFLP analyses of PvuII digests of genomic DNA. We used this probe to determine the RFLP patterns of 43 clinical isolates of M. haemophilum from 28 patients. A total of six distinct patterns were observed. Two patterns, designated types 1 and 2, accounted for 91% of the infections in patients from the New York City area. Two isolates from Arizona had identical patterns but were distinct from those of New York isolates, and an isolate from Israel, the type strain, had another distinct pattern (type 6). The type 6 pattern was also seen in a recent isolate from Norway. All of the type 1 isolates and 60% of the type 2 isolates were recovered from patients with AIDS in the New York City area. This molecular subtyping method should provide a useful tool for epidemiological studies and may help identify the associated risk factors, vehicles, and possible reservoirs of this newly emerging pathogen.

Entities:  

Mesh:

Year:  1994        PMID: 7929771      PMCID: PMC263787          DOI: 10.1128/jcm.32.7.1763-1767.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Unusual mycobacteria in 5 cases of opportunistic infections.

Authors:  A Mezo; F Jennis; S W McCarthy; D J Dawson
Journal:  Pathology       Date:  1979-07       Impact factor: 5.306

3.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.

Authors:  J D van Embden; M D Cave; J T Crawford; J W Dale; K D Eisenach; B Gicquel; P Hermans; C Martin; R McAdam; T M Shinnick
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

4.  Mycobacteria with a growth requirement for ferric ammonium citrate, identified as Mycobacterium haemophilum.

Authors:  D J Dawson; F Jennis
Journal:  J Clin Microbiol       Date:  1980-02       Impact factor: 5.948

5.  Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS.

Authors:  L L Dever; J W Martin; B Seaworth; J H Jorgensen
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

6.  Osteomyelitis caused by Mycobacterium haemophilum: successful therapy in two patients with AIDS.

Authors:  R L Yarrish; W Shay; V J LaBombardi; M Meyerson; D K Miller; D Larone
Journal:  AIDS       Date:  1992-06       Impact factor: 4.177

7.  Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection.

Authors:  P M Small; R W Shafer; P C Hopewell; S P Singh; M J Murphy; E Desmond; M F Sierra; G K Schoolnik
Journal:  N Engl J Med       Date:  1993-04-22       Impact factor: 91.245

8.  Two cases of Mycobacterium haemophilum infection in Canada.

Authors:  L Thibert; F Lebel; B Martineau
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

9.  Mycobacterium haemophilum causing lymphadenitis in an otherwise healthy child.

Authors:  D J Dawson; Z M Blacklock; D W Kane
Journal:  Med J Aust       Date:  1981-09-19       Impact factor: 7.738

Review 10.  Mycobacterium haemophilum infection in immunocompromised patients: case report and review of the literature.

Authors:  M Kristjansson; V M Bieluch; P D Byeff
Journal:  Rev Infect Dis       Date:  1991 Sep-Oct
View more
  5 in total

Review 1.  Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans.

Authors:  M A Saubolle; T E Kiehn; M H White; M F Rudinsky; D Armstrong
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

2.  Differentiation of Mycobacterium ulcerans, M. marinum, and M. haemophilum: mapping of their relationships to M. tuberculosis by fatty acid profile analysis, DNA-DNA hybridization, and 16S rRNA gene sequence analysis.

Authors:  T Tønjum; D B Welty; E Jantzen; P L Small
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

Review 3.  Clinical manifestations, diagnosis, and treatment of Mycobacterium haemophilum infections.

Authors:  Jerome A Lindeboom; Lesla E S Bruijnesteijn van Coppenraet; Dick van Soolingen; Jan M Prins; Eduard J Kuijper
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

Review 4.  Emergence of a unique group of necrotizing mycobacterial diseases.

Authors:  K M Dobos; F D Quinn; D A Ashford; C R Horsburgh; C H King
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

5.  The Complete Genome Sequence of the Emerging Pathogen Mycobacterium haemophilum Explains Its Unique Culture Requirements.

Authors:  JoAnn M Tufariello; Christopher A Kerantzas; Catherine Vilchèze; R Brent Calder; Eric K Nordberg; Jack A Fischer; Travis E Hartman; Eva Yang; Timothy Driscoll; Laura E Cole; Robert Sebra; Shahina B Maqbool; Alice R Wattam; William R Jacobs
Journal:  mBio       Date:  2015-11-17       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.